Methods useful for the treatment of pain, arthritic conditions or inflammation associated with a chronic condition

a technology of chronic conditions and pain, applied in the direction of heterocyclic compound active ingredients, biocide, drug compositions, etc., can solve the problems of oxycodone marketed versions, limited use, dependence and abuse,

Inactive Publication Date: 2009-12-03
DURECT CORP
View PDF100 Cites 39 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0012]In some embodiments, the chronic pain is associated with a joint, hip, knee, back, neck, or lower back of the subject. In some embodiments, the pain is measured as pain intensity. In some embodiments, the pain intensity is attenuated as compared to a pain intensity baseline of the subject. In some embodiments the pain is measured on the pain subscale of the WOMAC Osteoarthritis Index. In some embodiments, the pain measurement of the subject is improved with administration of the opioid as compared to baseline pain measurement of the subject on the WOMAC pain subscale baseline of the subject.
[0027]Advantages of methods of the invention include enhanced and prolonged analgesia, prevention of tolerance and continued protection against tolerance even with chronic administration, reversal of opioid-induced hyperalgesia, prevention of physical dependence or withdrawal, decreased rewarding / euphoric side effect, and / or decreased potential for relapse / addiction.

Problems solved by technology

Opioids are a broad class of drugs used clinically in the management of pain, but their use is limited by a constellation of undesirable side effects, including their potential for dependence and abuse.
However, marketed versions of controlled-release oxycodone have been the subject of intense media scrutiny due to an epidemic of misuse, abuse and diversion.
Abusers can easily disrupt the controlled-release mechanism of OxyContin by crushing, chewing or dissolving tablets or capsules in alcohol, leading to an immediate surge in oxycodone blood levels, which can produce a sense of euphoria but can also lead to respiratory depression and even death.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods useful for the treatment of pain, arthritic conditions or inflammation associated with a chronic condition
  • Methods useful for the treatment of pain, arthritic conditions or inflammation associated with a chronic condition
  • Methods useful for the treatment of pain, arthritic conditions or inflammation associated with a chronic condition

Examples

Experimental program
Comparison scheme
Effect test

example 1

Evaluation of the Efficacy and Safety of an Oral Opioid Pharmaceutical Composition

[0268]A clinical trial of an exemplary oral opioid pharmaceutical composition was conducted as follows. The “study drug” used in the clinical trial is a controlled release oral formulation containing oxycodone as the API. The clinical trial was conducted in subjects with moderate to severe chronic pain due to osteoarthritis of the hip or knee. A primary objective of the clinical trial was to study the efficacy and safety of the study drug in these subjects. A secondary objective of the clinical trial was to compare quality of life measures in these subjects with moderate to severe chronic pain due to osteoarthritis of the hip or knee who receive the study drug as compared with those who receive placebo.

[0269]For this clinical trial, a multicenter, randomized, double-blind, placebo-controlled, phase III study was conducted in approximately four hundred subjects with moderate to severe chronic pain due t...

example 2

Preparation of Opioid Formulations

[0532]Exemplary opioid dosage forms comprising oxycodone are prepared as described herein. For clinical studies as described in Example 1, capsules having different amounts of oxycodone are produced.

[0533]Capsule formulations containing oxycodone at various dose levels (5.0, 10.0, 20.0, 30.0 and 40.0 mg / capsule) and matching placebo capsules are prepared.

[0534]The components, pharmaceutical grade, and function of each component used to make oxycodone capsules are provided in Table 16 below.

TABLE 16Components for Oxycodone CapsulesComponentFunctionOxycodone base (micronized)Active pharmaceutical ingredientSucrose acetate isobutyrateLiquid carrier materialTriacetin, USPSolventIsopropyl myristate, NFRheology modifierCellulose acetate butyrate, NF / EP,Network formerethanol washed (grade 381-20 BP)Hydroxyethyl cellulose, NFHydrophilic agentColloidal silicon dioxide, NFViscosity enhancing agentButylated hydroxytoluene, NFAntioxidantHard gelatin capsuleDosa...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
timeaaaaaaaaaa
timeaaaaaaaaaa
timeaaaaaaaaaa
Login to view more

Abstract

Methods, including those for administering novel pharmaceutical compositions, dosage forms containing an opioid active pharmaceutical ingredient, are useful for treating pain, arthritic conditions and / or inflammation associated with a chronic condition, including pain from arthritis and inflammation.

Description

FIELD OF THE INVENTION[0001]The present invention relates to methods, including novel methods of administration, useful for the treatment of pain, arthritic conditions, and / or inflammation associated with a chronic condition, using opioid compositions. The methods provide human subjects with an alleviation of one or more symptoms or signs of pain, an arthritic condition or inflammation associated with a chronic condition, including, for example, reduced pain, reduced stiffness and / or improved physical function.BACKGROUND OF THE INVENTION[0002]Opioids are a broad class of drugs used clinically in the management of pain, but their use is limited by a constellation of undesirable side effects, including their potential for dependence and abuse. The principle actions and therapeutic value of opioids are analgesia and sedation. The precise mechanisms of action for these effects are unknown; however, specific central nervous system opioid receptors for endogenous compounds with opioid-lik...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/4355A61K31/34
CPCA61K9/4858A61K9/4866A61K9/48A61K31/4402A61K31/485A61K31/137A61K31/4458A61P19/00A61P19/02A61P25/00A61P25/04A61P25/20A61P25/24A61P25/26A61P25/36A61P29/00A61P35/00A61P43/00
Inventor YUM, SU ILCHAO, WENDYFU, ROGERZAMLOOT, MICHAEL
Owner DURECT CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products